Skip to main content

Table 7 Composition of HIV-1 envelope peptide pools tested

From: Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model

Peptide Pools W61D IIIB SF33
V1/V2 Pool ARP7035.6-17 ARP740.6-16 ARP7117.6-16
V3 Pool ARP7035.22, 25-33 ARP740.21, 24-33 ARP7117.21, 24-33
V4 Pool ARP7035.34-38, 41-48 ARP740.33-38, 41-47 ARP7117.33-38,41-46
C1 Pool ARP7035.1-5, 20, 21 nt nt
C2 Pool ARP7035.18, 19, 23, 24 nt ARP7117.17, 18, 22, 23
C3 Pool ARP7035.39, 40 nt nt
  1. nt = not tested.
  2. 20mer HIV-1 env gp120 peptides with 10mer overlap from CFAR, NIBSC, UK.